+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
From
From
Uropathy Treatment - Global Strategic Business Report - Product Thumbnail Image

Uropathy Treatment - Global Strategic Business Report

  • Report
  • June 2025
  • 67 Pages
  • Global
From
Janus Kinase (JAK) Inhibitors Market Report 2025 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
Tarceva - Product Thumbnail Image

Tarceva

  • Report
  • August 2018
  • 25 Pages
  • Global
From
Blood Glucose Monitoring Devices Market Outlook, 2028 - Product Thumbnail Image

Blood Glucose Monitoring Devices Market Outlook, 2028

  • Report
  • November 2023
  • 190 Pages
  • Global
From
Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • April 2025
  • 1432 Pages
  • Global
From
Immunosuppressant Drugs Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Immunosuppressant Drugs Market - Forecasts from 2025 to 2030

  • Report
  • December 2024
  • 145 Pages
  • Global
From
From
Loading Indicator